- 睿智醫藥
- 9.820+0.050 (+0.512%)
盈利能力分析
- 0.575
- -17.089
- -48.477
- 16.827
- -18.316
- 0.356
- -10.224
- -29.372
- 9.037
- -9.647
- 0.400
- -11.502
- -32.939
- 10.070
- -10.735
邊際利潤分析
- 27.553
- 21.800
- 25.935
- 25.423
- 31.690
- 1.705
- -22.350
- -82.255
- 56.350
- -21.021
- 2.440
- -23.476
- -81.322
- 55.826
- -16.483
- 0.877
- -23.347
- -80.549
- 27.320
- -23.783
收益指標分析
- 6.272
- 26.521
- 6.392
- -11.315
- 2.377
- 93.731
- -3.365
- 0.098
- 190.871
- -3.061
- 5.563
- 6.392
- 0.362
- -2.575
- 1.559
償債能力分析
- 2.096
- 1.858
- 1.704
- 1.749
- 0.694
- 2.069
- 1.825
- 1.639
- 1.691
- 0.625
- 35.770
- 37.967
- 39.988
- 37.762
- 52.839
- 9.617
- 10.546
- 10.329
- 15.544
- 31.887
- 736.559
- 648.516
- 643.036
- 443.387
- 162.182
- 176.154
- 160.194
- 147.585
- 163.121
- 88.150
- 3.846
- -58.773
- -66.008
- 62.684
- -3.384
營運能力分析
- 61.938
- 81.738
- 95.718
- 91.814
- 76.617
- 4.707
- 9.329
- 15.094
- 20.310
- 19.267
大國博弈
回顧25 展望26
More